Benzopyranone compounds for treating cancer

Details for Australian Patent Application No. 2006262190 (hide)

Owner Signal Pharmaceuticals, LLC.

Inventors Sakata, Steven T.; Missbach, Martin; Narla, Rama Krishna; Renaud, Johanne; Stein, Bernd

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006262190

PCT Pub. Number WO2007/002272

Priority 60/693,867 24.06.05 US

Filing date 22 June 2006

Wipo publication date 4 January 2007

International Classifications

C07D 311/18 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002272 Priority application(s): WO2007/002272

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006262195-Dronabinol treatment for migraines

2006262185-Nucleotide sequences mediating plant male fertility and method of using same